(0.72%) 5 054.37 points
(0.68%) 38 163 points
(1.23%) 15 797 points
(0.03%) $79.02
(5.33%) $2.04
(0.02%) $2 311.40
(0.66%) $26.93
(1.21%) $966.45
(-0.04%) $0.933
(-0.31%) $11.00
(-0.03%) $0.798
(-1.36%) $91.99
Live Chart Being Loaded With Signals
tella, Inc. researches and develops regenerative and cell medicines. The company offers techniques and operational knowhow associated with dendritic cell vaccine therapy to affiliated medical institutions for the treatment of cancer...
Stats | |
---|---|
Šios dienos apimtis | 12.99M |
Vidutinė apimtis | 0 |
Rinkos kapitalizacija | 0.00 |
Last Dividend | ¥0.800 ( 2012-12-26 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | -0.0564 |
ATR14 | ¥0 (0.00%) |
tella, Inc. Koreliacija
10 Labiausiai teigiamai susiję koreliacijos |
---|
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
tella, Inc. Finansinės ataskaitos
Annual | 2021 |
Pajamos: | ¥106.41M |
Bruto pelnas: | ¥-98.59M (-92.65 %) |
EPS: | ¥-9.04 |
FY | 2021 |
Pajamos: | ¥106.41M |
Bruto pelnas: | ¥-98.59M (-92.65 %) |
EPS: | ¥-9.04 |
FY | 2020 |
Pajamos: | ¥76.36M |
Bruto pelnas: | ¥-37.44M (-49.02 %) |
EPS: | ¥-45.26 |
FY | 2019 |
Pajamos: | ¥202.18M |
Bruto pelnas: | ¥44.81M (22.16 %) |
EPS: | ¥-53.81 |
Financial Reports:
No articles found.
tella, Inc. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
First Dividend | ¥0.600 | 2010-12-28 |
Last Dividend | ¥0.800 | 2012-12-26 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 2 | -- |
Total Paid Out | ¥1.400 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 0.22 | -- |
Div. Sustainability Score | 0 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 0 | -- |
Year | Amount | Yield |
---|
The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
8052.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
7298.T | Ex Dividend Knight | 2023-09-28 | Annually | 0 | 0.00% | |
6547.T | Ex Dividend Junior | 2024-06-27 | Sporadic | 0 | 0.00% | |
5901.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
4559.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
3798.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
3064.T | Ex Dividend Knight | 2023-12-28 | Semi-Annually | 0 | 0.00% | |
1945.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
9832.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
8897.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -8.92 | 1.500 | -10.00 | -10.00 | [0 - 0.5] |
returnOnAssetsTTM | -2.91 | 1.200 | -10.00 | -10.00 | [0 - 0.3] |
returnOnEquityTTM | -1.442 | 1.500 | -10.00 | -10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 5.18 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 1.043 | 0.800 | 8.57 | 6.85 | [0.8 - 2.5] |
cashRatioTTM | 1.043 | 1.500 | 5.31 | 7.97 | [0.2 - 2] |
debtRatioTTM | 0.00805 | -1.500 | 9.87 | -10.00 | [0 - 0.6] |
interestCoverageTTM | -6 403.73 | 1.000 | -10.00 | -10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | -7.57 | 2.00 | -2.52 | -5.05 | [0 - 30] |
freeCashFlowPerShareTTM | -7.57 | 2.00 | -3.79 | -7.57 | [0 - 20] |
debtEquityRatioTTM | 0.0132 | -1.500 | 9.95 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | -0.927 | 1.000 | -10.00 | -10.00 | [0.2 - 0.8] |
operatingProfitMarginTTM | -7.46 | 1.000 | -10.00 | -10.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -309.84 | 1.000 | -10.00 | -10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.326 | 0.800 | -1.160 | -0.928 | [0.5 - 2] |
Total Score | -4.17 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -0.227 | 1.000 | -0.124 | 0 | [1 - 100] |
returnOnEquityTTM | -1.442 | 2.50 | -10.00 | -10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -7.57 | 2.00 | -2.52 | -7.57 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -7.57 | 2.00 | -2.52 | -5.05 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.00699 | 1.500 | -3.29 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | -7.65 | 1.000 | -10.00 | 0 | [0.1 - 0.5] |
Total Score | -3.51 |
tella, Inc.
tella, Inc. researches and develops regenerative and cell medicines. The company offers techniques and operational knowhow associated with dendritic cell vaccine therapy to affiliated medical institutions for the treatment of cancer. It is also involved in the provision of consultation services on the establishment and maintenance of cell processing centers, and on introduction of management systems for cell cultivation; and lease of standard operating procedure and regular checks on manufacturing operation management and training of cell cultivation technicians. In addition, the company provides consultation services on training of expertise regarding treatment practice; and support services for the assessment of therapies, documentation required for treatment practice, and cognition and information providing activities for physicians and patients. tella, Inc. was founded in 2004 and is based in Tokyo, Japan.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.